Volume | 415,961 |
|
|||||
News | - | ||||||
Day High | 43.59 | Low High |
|||||
Day Low | 41.89 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Soleno Therapeutics Inc | SLNO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
43.05 | 41.89 | 43.59 | 42.08 | 42.63 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
5,337 | 415,961 | US$ 42.60 | US$ 17,720,528 | - | 3.69 - 53.82 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:56:52 | 10 | US$ 41.60 | USD |
Soleno Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.36B | 32.46M | - | 0 | -38.99M | -1.20 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Soleno Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SLNO Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 41.36 | 43.73 | 39.64 | 41.61 | 315,820 | 0.72 | 1.74% |
1 Month | 47.14 | 48.49 | 39.64 | 44.47 | 436,693 | -5.06 | -10.73% |
3 Months | 44.26 | 53.80 | 36.61 | 43.31 | 424,401 | -2.18 | -4.93% |
6 Months | 28.45 | 53.82 | 27.27 | 42.41 | 381,183 | 13.63 | 47.91% |
1 Year | 5.30 | 53.82 | 3.69 | 31.34 | 497,834 | 36.78 | 693.96% |
3 Years | 1.04 | 53.82 | 0.1302 | 6.86 | 860,090 | 41.04 | 3,946.15% |
5 Years | 2.90 | 53.82 | 0.1302 | 5.29 | 747,699 | 39.18 | 1,351.03% |
Soleno Therapeutics Description
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. |